In patients w/ FH w/o previous clinical #ASCVD on statin treatment w/ or w/o ezetimibe, the PCSK9 inhibitor alirocumab resulted in a significant regression of the coronary atherosclerotic burden. Read more about the study: https://t.co/ClII4FVn94 #cvPrev
Haven’t heard of Lpa??? It’s a type of lipoprotein (cholesterol) that runs in families and puts one at risk for heart attack & stroke. Visit https://t.co/uvDLUBAQ5P & raise awareness today on Lipoprotein (a) Awareness Day! #KnowLpa@northwell@lenoxhill
Last night at the Gridiron Dinner in DC, maybe 10 feet from me and @sarahagruen, a woman collapsed, hit her head on a table, and was laying on the floor without moving.
People gather trying to help, but no one is sure what to do. Someone goes to find a doctor.
They found one.
I say this ALL the time to new attendings. As a cardiac ICU attending with complex sick patients, synthesizing a thorough note (which also makes sense to other providers) helps my cognitive thinking and will absolutely help a patient @Diala_steitieh@drtracykpaul@JSpitz_MD
A surprise reveal of our @nyphospital Lower Manhattan 2023 Physician of the Year Dr. Altaf Pirmohamed, Cardiology ! Received multiple nominations for his collaboration, collegiality, kindness and respect ! Looking forward to celebrating March 30th! #doctorsday @WillieMManzano
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients: @NEJM@ACCinTouch#ACC23#Trial Update 2
Editorializing: 15% of study population are older adults = @MichaelGNanna@Ajar_Kochar
Clear Outcome Trial: 8 Point Summary Below
👇👇👇
#EVOLUT Low Risk Trial #ACC23#WCCardio#LBCT
🫀TAVR vs SAVR in Low risk: 3 year follow up
🫀���️☠️ or stroke out to Year 3 in TAVR arm vs SAVR (7.4% vs 10%): 30% Risk reduction
🫀Seen in all groups
🫀⤴️ ppm in TAVR, ⤴️ Afib in SAVR
🫀no diff in paravalv regurg